Check-Cap’s C-Scan system is an ingestible capsule that detects colorectal polyps before they turn into colorectal cancer. The company uses tracking technology to follow the capsule’s movement throughout a patient’s body for real-time activation.
The patent comes after the company’s announcement that it would be expanding its manufacturing capacity in preparation for a U.S. study being launched next year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
